Journal: Frontiers in Immunology
Article Title: The transcription factor Nrf2 links Th2-mediated experimental allergy to food preservatives
doi: 10.3389/fimmu.2024.1476480
Figure Lengend Snippet: Sensitization and anaphylaxis to OVA is markedly diminished in SCID mice receiving Nrf2-deficient CD4 + T cells by adoptive transfer. SCID mice received wild-type or Nrf2-deficient CD4 + T cells via adoptive transfer (all animals received wild-type B cells) prior to OVA sensitization. Plasma levels of (A) : OVA-IgE (at 1/40 dilution) or (B) : OVA-IgG1 (at 1/2000 dilution) from individual animals were quantified by ELISA. *p < 0.05 as determined by two-way ANOVA with Bonferroni’s multiple comparisons test for post hoc analysis (n=7/WT on the control diet group, n=6/KO on the control diet group, n=7/WT on the diet with tBHQ group, n=7/KO on the diet with tBHQ). Data are presented as mean ± SE. (C-H) SCID mice receiving wild-type or Nrf2-deficient CD4 + T cells via adoptive transfer were challenged orally to OVA one week after the final sensitization. Rectal temperatures recorded before and at every 10 min after oral challenge in mice receiving (C) WT or (D) Nrf2-deficient CD4 + T cells. (E) Clinical scores of mice orally challenged with OVA (10 mg/mouse). (F) mMCP-1 plasma levels 1 h after oral challenge as determined by ELISA. The expression levels of (G) GATA3 and (H) IL-4 in CD4 + T cells as determined by mean fluorescence intensity by flow cytometry. Data are presented as mean ± SE. *p < 0.05 as determined by two-way ANOVA followed by Holm-Sidak or Bonferroni’s post hoc test (n=6-7). ND, Not detected. Statistical analysis for clinical scores between multiple groups was performed using a Kruskal-Wallis test with Dunn’s post hoc test.
Article Snippet: Spleen cells (2 × 10 6 cells/ml) in DMEM (Genesee Scientific, El Cajon, CA) containing 10% fetal bovine serum (Gibco), 25 mM HEPES (Sigma), 10 mM nonessential amino acids (Sigma), 100 u/mL penicillin-streptomycin solution (Sigma), and 55μM 2-mercaptoethanol (Invitrogen) were first stimulated with anti-CD3 (1.5 μg/ml) (eBioscience Inc., San Diego, CA)/anti-CD28 (1.5 μg/ml) (Invitrogen) and crosslinker AffiniPure F(ab’) 2 Fragment Goat Anti-Syrian Hamster IgG(H+L) (1.5 μg/ml) (Jackson ImmunoResearch, West Grove, PA, USA) for 72 hours in the presence of 2 mM monensin (Biolegend, San Diego, CA), and then stained with viability dye (eBioscience Inc., San Diego, CA) and antibodies to cell surface markers, CD3-AF488 (Biolegend, San Diego, CA), CD4 + -PE/Cy7 (eBioscience Inc., San Diego, CA) and CD8a-PerCP/Cy5.5 (Biolegend, San Diego, CA).
Techniques: Adoptive Transfer Assay, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Control, Expressing, Fluorescence, Flow Cytometry